BIO-PATH HOLDINGS INC BPTH Income Statement

Bio-path holdings inc (BPTH)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	13	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Operating expenses
Research and development
6,195	4,585	3,798	4,765	4,069	4,603	5,492	4,733	5,386	5,480	5,043	5,773	5,480	5,474	5,391	4,070	3,447	3,020	2,729	2,162	2,115	1,630	0	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-
General and administrative
4,322	4,108	3,784	3,628	3,514	3,379	3,394	3,547	3,540	3,523	3,435	3,223	3,135	3,014	2,879	2,718	2,528	2,465	2,739	2,932	3,120	2,715	2,192	2,289	1,775	1,634	1,547	982	994	986	952	1,033	1,105	1,224	1,268	1,236	0	0	0
Total operating expenses
10,517	8,693	8,190	9,001	8,191	8,590	8,886	8,280	8,926	9,003	8,478	8,996	8,615	8,488	8,270	6,788	5,975	5,485	5,624	5,266	5,410	4,542	3,730	3,969	3,123	3,269	2,910	2,356	2,715	2,582	2,955	2,619	2,295	2,365	2,062	1,984	0	0	0
Net operating loss
-10,517	-8,693	-8,190	-9,001	-8,191	-8,590	-8,849	-8,243	-8,889	-8,966	-8,465	-8,983	-8,602	-8,475	-8,270	-6,788	-5,975	-5,485	-5,624	-5,266	-5,410	-4,542	-3,730	-3,969	-3,123	-3,269	-2,910	-2,356	-2,715	-2,582	-2,955	-2,619	-2,295	-2,365	-2,062	-1,984	0	0	0
Other income (loss)
Change in fair value of warrant liability
-	-	-	-	-	-	-	-	-	-2,374	-2,667	-4,087	-3,309	-1,713	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on extinguishment of warrant liability
-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest income
106	94	71	43	12	7	8	9	9	9	11	13	13	12	13	13	16	18	18	20	21	23	18	14	9	4	2	1	0	0	1	2	3	2	2	1	0	0	0
Other income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0	-	0	-	-	-	-
Other expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total other income
106	94	71	43	12	7	8	9	347	1,943	2,238	3,660	3,322	1,725	1,433	13	16	18	18	20	21	23	18	13	8	3	1	1	-0	0	0	1	2	2	1	1	0	0	0
Net loss before income taxes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-
Net loss
-10,411	-8,599	-8,119	-8,958	-8,179	-8,583	-8,841	-8,234	-8,542	-7,023	-6,227	-5,323	-5,280	-6,750	-6,837	-6,775	-5,959	-5,467	-5,605	-5,246	-5,389	-4,519	-3,711	-3,956	-3,114	-3,266	-2,908	-2,355	-2,716	-2,582	-2,654	-2,276	0	-	0	0	-	0	0
Deemed dividend related to warrant conversion
-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss attributable to common stockholders
-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss per share, basic and diluted (in dollars)
-0.90	-0.70	-0.78	-0.87	-0.89	-2.66	-5.38	-2.96	-3.38	-15.39	-0.25	-0.31	-0.04	-0.67	-0.02	-0.02	-0.02	-0.01	-0.02	-0.01	-0.02	-0.02	-0.01	-0.01	-0.01	-0.01	-0.02	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01
Basic and diluted weighted average number of common shares outstanding
3,692	3,228	2,872	2,828	1,700	681	573	567	567	-27,414	10,006	9,859	9,565	-238,091	95,645	89,763	89,763	358,782	89	89	89	89,414	89,237	89,237	89,237	81,285	75,380	66,606	62,219	61,118	58,902	58,868	58,381	-	56,146	51,649	-	-	-
Basic and diluted weighted average number of common shares outstanding
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	49,400	49,083	47,565